Calculation of Prognostic Scores, Using Delayed Imaging, Outperforms Baseline Assessments in Acute Intracerebral Hemorrhage.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 11 3 2020
medline: 17 9 2020
entrez: 11 3 2020
Statut: ppublish

Résumé

Background and Purpose- Patients with intracerebral hemorrhage (ICH) are often subject to rapid deterioration due to hematoma expansion. Current prognostic scores are largely based on the assessment of baseline radiographic characteristics and do not account for subsequent changes. We propose that calculation of prognostic scores using delayed imaging will have better predictive values for long-term mortality compared with baseline assessments. Methods- We analyzed prospectively collected data from the multicenter PREDICT study (Prediction of Hematoma Growth and Outcome in Patients With Intracerebral Hemorrhage Using the CT-Angiography Spot Sign). We calculated the ICH Score, Functional Outcome in Patients With Primary Intracerebral Hemorrhage (FUNC) Score, and modified ICH Score using imaging data at initial presentation and at 24 hours. The primary outcome was mortality at 90 days. We generated receiver operating characteristic curves for all 3 scores, both at baseline and at 24 hours, and assessed predictive accuracy for 90-day mortality with their respective area under the curve. Competing curves were assessed with nonparametric methods. Results- The analysis included 280 patients, with a 90-day mortality rate of 25.4%. All 3 prognostic scores calculated using 24-hour imaging were more predictive of mortality as compared with baseline: the area under the curve was 0.82 at 24 hours (95% CI, 0.76-0.87) compared with 0.78 at baseline (95% CI, 0.72-0.84) for ICH Score, 0.84 at 24 hours (95% CI, 0.79-0.89) compared with 0.76 at baseline (95% CI, 0.70-0.83) for FUNC, and 0.82 at 24 hours (95% CI, 0.76-0.88) compared with 0.74 at baseline (95% CI, 0.67-0.81) for modified ICH Score. Conclusions- Calculation of the ICH Score, FUNC Score, and modified ICH Score using 24-hour imaging demonstrated better prognostic value in predicting 90-day mortality compared with those calculated at presentation.

Identifiants

pubmed: 32151235
doi: 10.1161/STROKEAHA.119.027119
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1107-1110

Auteurs

Ronda Lun (R)

From the Ottawa Stroke Program, Department of Medicine (Neurology), University of Ottawa, Canada (R.L., V.Y., D.D.).

Vignan Yogendrakumar (V)

From the Ottawa Stroke Program, Department of Medicine (Neurology), University of Ottawa, Canada (R.L., V.Y., D.D.).

Andrew M Demchuk (AM)

Calgary Stroke Program, Department of Clinical Neurosciences (A.M.D., M.D.H.), Hotchkiss Brain Institute, University of Calgary, Canada.
Department of Radiology (A.M.D., M.D.H.), Hotchkiss Brain Institute, University of Calgary, Canada.

Richard I Aviv (RI)

Division of Neuroradiology (R.I.A.), Sunnybrook Health Sciences Centre, University of Toronto, Canada.
Department of Medical Imaging (R.I.A.), Sunnybrook Health Sciences Centre, University of Toronto, Canada.

David Rodriguez-Luna (D)

Department of Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain (D.R.-L., C.A.M.).

Carlos A Molina (CA)

Department of Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain (D.R.-L., C.A.M.).

Yolanda Silva (Y)

Department of Neurology, Dr. Josep Trueta University Hospital, Institut d'Investigació Biomèdica Girona Foundation, Girona, Spain (Y.S.).

Imanuel Dzialowski (I)

Department of Neurology, Elblandklinikum Meissen Academic Teaching Hospital of the Technische University, Dresden, Germany (I.D.).

Adam Kobayashi (A)

Interventional Stroke and Cerebrovascular Treatment Center, Institute of Psychiatry and Neurology, Warsaw, Poland (A.K.).
2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland (A.K.).
Department of Experimental and Clinical Pharmacology, Warsaw, Poland (A.K.).

Jean-Martin Boulanger (JM)

Department of Medicine, Charles LeMoyne Hospital, University of Sherbrooke, Longueuil, Canada (J.-M.B.).

Gordon Gubitz (G)

Department of Neurology, Dalhousie University, Halifax, Canada (G.G.).

Padma Srivastava (P)

Department of Neurology, All India Institute of Medical Sciences, New Delhi (P.S., R.B.).

Jayanta Roy (J)

Apollo Gleneagles Hospitals, Kolkata, India (J.R.).

Carlos S Kase (CS)

Department of Neurology, Boston Medical Center, MA (C.S.K.).

Rohit Bhatia (R)

Department of Neurology, All India Institute of Medical Sciences, New Delhi (P.S., R.B.).

Michael D Hill (MD)

Calgary Stroke Program, Department of Clinical Neurosciences (A.M.D., M.D.H.), Hotchkiss Brain Institute, University of Calgary, Canada.
Department of Radiology (A.M.D., M.D.H.), Hotchkiss Brain Institute, University of Calgary, Canada.

Dar Dowlatshahi (D)

From the Ottawa Stroke Program, Department of Medicine (Neurology), University of Ottawa, Canada (R.L., V.Y., D.D.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH